MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3760/cma.j.cn112139-20241107-00496

Медицинская библиотека · Zhonghua wai ke za zhi [Chinese journal of surgery] · 2025

[One-year outcomes of a novel domestic transcatheter aortic valve system in severe aortic stenosis: a multicenter cohort study].

Li Y H, Zhou J W, Wei L, Guo Y Y, Ma L, Guo H M, Pan X B, Wang D J, Luo F Y, Wang J, Wei M X, Feng D G, Xiao Y B, Liu L M, Wang J A, Wang J G, Zhang H B

СтатьяМногоцентровое исследованиеАннотация на английскомПеревод пока не подготовлен

Аннотация

Objective

To examine the safety and effectiveness of a novel domestic transcatheter aortic valve system in addressing severe aortic valve stenosis.

Methods

This prospective, multicenter, single-arm target-value clinical trial enrolled patients with severe aortic stenosis meeting inclusion criteria from 13 Chinese centers between July 2021 and April 2022. The primary endpoint was all-cause mortality at 1-year post-procedure. Secondary endpoints included safety outcomes (30-day all-cause mortality, 1-year major adverse cardiovascular events, device success) and efficacy parameters (transvalvular pressure gradient, paravalvular leak severity, New York Heart Association(NYHA)class improvement, and quality of life). Survival analysis was performed using the Kaplan-Meier analysis.

Results

The study included 134 patients, 85 males and 49 females, with an age of (73.6±5.6)years (range: 65.1 to 91.8 years). Bicuspid aortic valve morphology was present in 59.7% (80/134). Device success rate was 99.3%, with one case converted to open surgery due to coronary obstruction. All-cause mortality was 0.8% (95%CI: 0.1% to 5.3%) at both 30-day and 1-year follow-up, significantly lower than the 25% target value (P<0.01). Permanent pacemaker implantation rates remained 2.2% (3/134) at both timepoints. Stroke incidence was 0.7% (1/134) at 30 days and 1.5% (2/134) at 1 year. Myocardial infarction rates were 0.7% (1/134) at both intervals. The postoperative transvalvular pressure gradient of the aortic valve was (6.6±3.1) mmHg(1 mmHg=0.133 kPa) (range: 4 to 8 mmHg). Among the patients, 32 cases (23.9%) had mild paravalvular leakage, 4 cases (3.0%) had moderate paravalvular leakage, and no severe paravalvular leakage was observed. NYHA class Ⅰ and Ⅱ patients increased from 18.7% preoperatively to 99.3% postoperatively.

Conclusion

The novel domestic transcatheter aortic valve system demonstrates satisfactory 1-year safety and efficacy outcomes in treating severe aortic stenosis.

Для цитирования: Li Y H, Zhou J W, Wei L, Guo Y Y, Ma L, Guo H M, Pan X B, Wang D J, Luo F Y, Wang J, Wei M X, Feng D G, Xiao Y B, Liu L M, Wang J A, Wang J G, Zhang H B. [One-year outcomes of a novel domestic transcatheter aortic valve system in severe aortic stenosis: a multicenter cohort study].. Zhonghua wai ke za zhi [Chinese journal of surgery]. 2025. DOI: 10.3760/cma.j.cn112139-20241107-00496.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.